PTHL Pheton Holdings Limited: Company Book Value

Public company logo of Pheton (PTHL)

Pheton Holdings Ltd (PTHL) develops software for precision tumor irradiation by integrating AI into diagnostics. The business relies on stable demand in China, as oncological care remains independent of market cycles. The price trend on GURU.Markets is currently at 0.00. However, the company lacks the pricing power to dictate the cost of its IT solutions to state clinics due to the pilot status of its product implementation.

PTHL - Pheton Holdings Book Capitalization over the range 09/06/2024 - 01/16/2026
Mass-produced product of ftzy.com.cn

Investors are assessing the resilience of Pheton Holdings Ltd (PTHL) through the spread between net assets and debt obligations, which determines the business's actual intrinsic value. By analyzing the total book capitalization metric on GURU.Markets, one can determine how effectively the logistics infrastructure for vegetable raw material supplies has been capitalized into equity, thereby avoiding overpaying for the asset or maintaining unjustified growth expectations.

Competitor analysis for Pheton Holdings Ltd

Accounting Value of Company HLN (Haleon Corp)|Kenvue Inc. (KVUE) - Company Book Value|VRNA (veronapharma.com) - Company Book Value|Company Book Value Jyong Biotech|Ligand Pharmaceuticals Incorporated - Net Asset Value|Book Capitalization AMRX|PRGO (Perrigo Corp) - Accounting Value of Company|Book Capitalization ALVO (Alvotech)|Book Capitalization liquidia.com LQDA|GLPG - Company Book Value|Accounting Value of Company ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. (MNKD) - Company Book Value|Company Net Assets Amphastar Corp|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com|Company Net Assets TBPH (Theravance Biopharma, Inc.)|AQST (Aquestive Therapeutics Inc) - Accounting Value of Company|Company Book Value scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Total Stockholders' Equity|TNXP: Company Net Assets|China SXT Pharmaceuticals - Total Net Assets|EPRX: Book Capitalization|BioHarvest Sciences, Inc. - Accounting Value of Company|EXOZ (Invizyne Technologies, Inc.) - Book Capitalization|Total Stockholders' Equity Oramed Pharma ORMP|Company Book Value Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Accounting Value of Company|Company Book Value ABVC BioPharma, Inc. ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Net Asset Value|Quantum BioPharma Limited - Book Capitalization|Accounting Value of Company FGEN (FibroGen Corporation)|TELO: Book Capitalization|Total Stockholders' Equity Rani Therapeutics Holdings, Inc. (RANI)|Company Net Assets SNYR|RLYB (Rallybio Corp.) - Total Net Assets|Company Book Value Lexaria Bioscience (LEXX)|PULM - Total Stockholders' Equity|Company Book Value Aptorum Group APM|LYRA: Accounting Capitalization|IBO: Company Net Assets|Accounting Value of Company TNFA (TNF Pharmaceuticals)|YCBD: Book Capitalization|PainReform Corp - Accounting Value of Company|Company Book Value Altamira Therapeutics Ltd|Total Stockholders' Equity lipella.com LIPO|Company Book Value OptiNose (OPTN)|Company Book Value PIRS (Pieris Pharmaceuticals Inc)|Book Capitalization PROC (Procaps Group SA)|PTPI: Accounting Capitalization|Qilian International - Book Capitalization|Book Valuation of Business acelyrin.com SLRN|TFF Pharmaceuticals, Inc. (TFFP) - Company Book Value